ES533485A0 - Procedimiento para producir un vehiculo de expresion de adn-replicable. - Google Patents

Procedimiento para producir un vehiculo de expresion de adn-replicable.

Info

Publication number
ES533485A0
ES533485A0 ES533485A ES533485A ES533485A0 ES 533485 A0 ES533485 A0 ES 533485A0 ES 533485 A ES533485 A ES 533485A ES 533485 A ES533485 A ES 533485A ES 533485 A0 ES533485 A0 ES 533485A0
Authority
ES
Spain
Prior art keywords
procedure
produce
dna expression
expression vehicle
replicable dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES533485A
Other languages
English (en)
Other versions
ES8605534A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES8605534A1 publication Critical patent/ES8605534A1/es
Publication of ES533485A0 publication Critical patent/ES533485A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES533485A 1982-03-08 1984-06-15 Procedimiento para producir un vehiculo de expresion de adn-replicable. Expired ES8605534A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35529882A 1982-03-08 1982-03-08
US43812882A 1982-11-01 1982-11-01

Publications (2)

Publication Number Publication Date
ES8605534A1 ES8605534A1 (es) 1986-04-01
ES533485A0 true ES533485A0 (es) 1986-04-01

Family

ID=26998783

Family Applications (2)

Application Number Title Priority Date Filing Date
ES520358A Expired ES8500327A1 (es) 1982-03-08 1983-03-07 Procedimiento para producir polipeptido
ES533485A Expired ES8605534A1 (es) 1982-03-08 1984-06-15 Procedimiento para producir un vehiculo de expresion de adn-replicable.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES520358A Expired ES8500327A1 (es) 1982-03-08 1983-03-07 Procedimiento para producir polipeptido

Country Status (17)

Country Link
EP (1) EP0088622B1 (es)
JP (4) JP2633227B2 (es)
AT (1) ATE123813T1 (es)
AU (1) AU572447B2 (es)
CA (1) CA1339936C (es)
DD (1) DD207732A5 (es)
DE (2) DE3308030C2 (es)
DK (1) DK171790B1 (es)
ES (2) ES8500327A1 (es)
FR (1) FR2530662B1 (es)
GB (1) GB2116566B (es)
IE (1) IE54592B1 (es)
IL (1) IL68059A (es)
NZ (1) NZ203493A (es)
PL (1) PL153902B1 (es)
PT (1) PT76353B (es)
YU (1) YU46722B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146281A (ja) * 1981-10-19 1983-08-31 Suntory Ltd 酵母細胞の形質転換法
US4751287A (en) * 1983-02-24 1988-06-14 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr Human leukocyte interferon N and a method of producing same in bacterial cells
ZA843275B (en) * 1983-05-05 1984-12-24 Hoffmann La Roche Novel vectors for interferon expression
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US4855231A (en) * 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
DE3500961A1 (de) * 1985-01-14 1986-07-17 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Escherichia-coli-staemme, dna-teilsequenzen dieser staemme und herstellungsverfahren
US4882282A (en) * 1985-08-16 1989-11-21 Immunex Corporation DNA sequences encoding bovine interleukin-2
US4709324A (en) * 1985-11-27 1987-11-24 Motorola, Inc. Data processor control unit having an interrupt service using instruction prefetch redirection
ZA877924B (en) * 1985-12-04 1987-08-26 Immunex Corp Cloning,characterization,and expression of bovine gamma interferon
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
ES2053585T3 (es) * 1986-12-12 1994-08-01 Ciba Geigy Ag Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.
ES2071612T3 (es) * 1987-12-29 1995-07-01 Toray Industries Plasmido sintetico, transformante, gen del interferon felino y metodo para producir interferon felino.
AU3365989A (en) * 1988-03-23 1989-10-16 University Of Georgia Research Foundation, Inc., The Large-scale production of bovine leukocyte interferon
CA2019803C (en) * 1989-06-29 2000-04-25 Akira Yanai Feline interferon and process for production thereof
US5641656A (en) * 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
US7338794B2 (en) * 2002-10-08 2008-03-04 Dow Agrosciences Llc Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant
WO2004046365A2 (en) * 2002-11-18 2004-06-03 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CN109206502B (zh) * 2018-09-26 2022-03-04 东北农业大学 一种猫干扰素ω及其制备方法和在抗病毒中的应用
CN112457391B (zh) * 2020-11-02 2022-10-04 天津大学 猪干扰素α、β、λ1在酿酒酵母中共分泌表达的方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons
JPS56131598A (en) * 1980-03-19 1981-10-15 Japan Found Cancer Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
EP0032134B2 (en) * 1980-01-08 1993-10-13 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
EP0042246B1 (en) * 1980-06-12 1987-03-18 The Cancer Institute Of Japanese Foundation For Cancer Research Plasmid
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
IT1139487B (it) * 1980-09-25 1986-09-24 Genentech Inc Produzione microbica di interferone di fibroblasti umani
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna

Also Published As

Publication number Publication date
PT76353B (en) 1986-02-27
ES520358A0 (es) 1984-11-01
JP2721139B2 (ja) 1998-03-04
JPH0948799A (ja) 1997-02-18
IL68059A0 (en) 1983-06-15
FR2530662B1 (fr) 1985-11-15
EP0088622A3 (en) 1984-08-01
PL240926A1 (en) 1983-10-24
PL153902B1 (en) 1991-06-28
JPH08187088A (ja) 1996-07-23
GB8306225D0 (en) 1983-04-13
DE3308030A1 (de) 1983-09-29
JPS58224690A (ja) 1983-12-27
AU1212283A (en) 1983-09-15
ES8500327A1 (es) 1984-11-01
DE3382789D1 (de) 1995-07-20
YU55583A (en) 1986-04-30
FR2530662A1 (fr) 1984-01-27
IE830471L (en) 1983-09-08
GB2116566B (en) 1985-11-27
DD207732A5 (de) 1984-03-14
CA1339936C (en) 1998-06-30
ES8605534A1 (es) 1986-04-01
EP0088622B1 (en) 1995-06-14
JPH06315385A (ja) 1994-11-15
AU572447B2 (en) 1988-05-12
DE3308030C2 (de) 1996-03-28
PT76353A (en) 1983-04-01
IL68059A (en) 1990-11-05
DK171790B1 (da) 1997-05-26
JP2633510B2 (ja) 1997-07-23
EP0088622A2 (en) 1983-09-14
YU46722B (sh) 1994-04-05
GB2116566A (en) 1983-09-28
JP2633227B2 (ja) 1997-07-23
DK111183A (da) 1983-09-09
NZ203493A (en) 1987-08-31
ATE123813T1 (de) 1995-06-15
IE54592B1 (en) 1989-12-06
DE3382789T2 (de) 1995-12-14
JP2677759B2 (ja) 1997-11-17
DK111183D0 (da) 1983-03-07

Similar Documents

Publication Publication Date Title
ES533485A0 (es) Procedimiento para producir un vehiculo de expresion de adn-replicable.
GR3021198T3 (en) Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
EP0216742A3 (en) Growth factors
FI103987B1 (fi) Interleukiini-7
MX9203645A (es) Nuevos interferones de humano y proceso biotecnologico para su produccion.
JPS55131399A (en) Cultivation of namalva cell and replacing animal serum protein by human albumine for producing interferon by said cell
GR3006212T3 (es)
DE3853590D1 (de) Rinder granulocyt-makrophagenkolonie stimulierender faktor.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050912